| Absorption |
| Blood-Brain Barrier | BBB- | 0.9907 |
| Human Intestinal Absorption | HIA- | 0.9382 |
| Caco-2 Permeability | Caco2- | 0.8252 |
| P-glycoprotein Substrate | Non-substrate | 0.5483 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9086 |
| Non-inhibitor | 0.9861 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9670 |
| Distribution |
| Subcellular localization | Lysosome | 0.4958 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8103 |
| CYP450 2D6 Substrate | Non-substrate | 0.8492 |
| CYP450 3A4 Substrate | Non-substrate | 0.5695 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9066 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9208 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9336 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9212 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9268 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9896 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9998 |
| Non-inhibitor | 0.9284 |
| AMES Toxicity | Non AMES toxic | 0.8670 |
| Carcinogens | Non-carcinogens | 0.6071 |
| Fish Toxicity | High FHMT | 0.7790 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6931 |
| Honey Bee Toxicity | Low HBT | 0.6705 |
| Biodegradation | Not ready biodegradable | 0.9654 |
| Acute Oral Toxicity | IV | 0.6254 |
| Carcinogenicity (Three-class) | Non-required | 0.6620 |